Asia Pacific Spirometer Market By End-use (Hospitals & Clinics and Home Healthcare), By Application (COPD, Pulmonary Fibrosis, Asthma, Cystic Fibrosis and Others), By Product Type (Table Top, Desktop and Hand Held), By Technology (Flow Measurement, Volume Measurement and Peak Flow Measurement), By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Spirometer Market
The Asia Pacific Spirometer Market would witness market growth of 12.1% CAGR during the forecast period (2020-2026). Portable spirometers have been becoming popular as they are compact and lightweight. Furthermore, these devices can store many diagnostic test results and can print the results on traditional printers. In addition, results can be sent to Electronic Medical Records (EMRs) of patients and flash drives.
Spirometry is rarely used for asthma diagnosis in pediatric patients, particularly in underdeveloped nations, where there is a higher burden of non-communicable diseases. The burden of non-communicable diseases can be reduced by deploying strategies to expand the spirometry assessment rate. The advanced spirometry devices standardize outcomes of tests and give fast response, unlike traditional devices. There has been a rising need for reduced hospital stay because of the prominence of ambulatory care settings.
Spirometry is widely performed in hospitals and clinics for the diagnosis and monitoring of chronic respiratory diseases. However, the home healthcare segment in Spirometer market is anticipated to register the highest growth rate over the forecast period. Homecare for patients suffering from respiratory disorders decreases morbidity, enhances the overall quality of life, and improves their chances of survival. The factors such as the introduction of new products and the adoption of telemedicine are likely to drive the growth of the segment.
Based on End-use, the market is segmented into Hospitals & Clinics and Home Healthcare. Based on Application, the market is segmented into COPD, Pulmonary Fibrosis, Asthma, Cystic Fibrosis and Others. Based on Product Type, the market is segmented into Table Top, Desktop and Hand Held. Based on Technology, the market is segmented into Flow Measurement, Volume Measurement and Peak Flow Measurement. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc., Smiths Group PLC (Smiths Medical, Inc.), Koninklijke Philips N.V., Medline Industries, Inc., Schiller AG, Vyaire Medical, Inc., SDI Diagnostics, Inc., Nihon Kohden Corporation, Koko LLC and Fukuda Sangyo Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Hospitals & Clinics
- Home Healthcare
- Pulmonary Fibrosis
- Cystic Fibrosis
By Product Type
- Table Top
- Hand Held
- Flow Measurement
- Volume Measurement
- Peak Flow Measurement
- South Korea
- Rest of Asia Pacific
- Hill-Rom Holdings, Inc.
- Smiths Group PLC (Smiths Medical, Inc.)
- Koninklijke Philips N.V.
- Medline Industries, Inc.
- Schiller AG
- Vyaire Medical, Inc.
- SDI Diagnostics, Inc.
- Nihon Kohden Corporation
- Koko LLC
- Fukuda Sangyo Co., Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free